Xenon Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 10.82 M | $629.10 M | 21.28% | 13.65% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 5.78 M | $335.98 M | 6.51% | 7.29% |
| BLACKROCK, INC. | 05/13/2026 | 5.64 M | $327.97 M | 10.58% | 7.12% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 4.83 M | $280.84 M | 1.36% | 6.09% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2026 | 4.49 M | $261.19 M | -1.04% | 5.67% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 4.41 M | $256.17 M | 78.66% | 5.56% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 4.18 M | $242.86 M | 2.25% | 5.27% |
| CAPITAL INTERNATIONAL INVESTORS | 05/13/2026 | 2.67 M | $155.54 M | -21.68% | 3.37% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.65 M | $154.27 M | 100.80% | 3.35% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.92 M | $106.86 M | 28.75% | 2.43% |
| STATE STREET CORP | 05/15/2026 | 1.72 M | $100.05 M | 15.27% | 2.17% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 1.68 M | $97.40 M | 34.00% | 2.11% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 1.62 M | $93.95 M | 198.09% | 2.04% |
| HOLOCENE ADVISORS, LP | 05/15/2026 | 1.52 M | $88.31 M | 18.45% | 1.92% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 1.40 M | $62.90 M | -11.95% | 1.77% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 05/11/2026 | 1.40 M | $81.50 M | 14.24% | 1.77% |
| CALIGAN PARTNERS LP | 05/15/2026 | 1.39 M | $81.00 M | 153.43% | 1.76% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 1.34 M | $78.04 M | 26.58% | 1.69% |
| BRAIDWELL LP | 05/15/2026 | 1.34 M | $77.83 M | -26.66% | 1.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.33 M | $77.32 M | 54.19% | 1.68% |
| JENNISON ASSOCIATES LLC | 05/06/2026 | 1.32 M | $76.69 M | 2.07% | 1.66% |
| SIREN, L.L.C. | 05/14/2026 | 1.32 M | $76.67 M | 62.23% | 1.66% |
| ALYESKA INVESTMENT GROUP, L.P. | 05/15/2026 | 1.30 M | $75.56 M | 100.00% | 1.64% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 1.28 M | $74.47 M | 68.93% | 1.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.09 M | $63.55 M | 14.72% | 1.38% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 1.06 M | $61.64 M | 137.02% | 1.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.05 M | $61.11 M | 2,044.69% | 1.33% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 982.20 K | $57.11 M | 238.69% | 1.24% |
| FEDERATED HERMES, INC. | 05/11/2026 | 972.24 K | $56.54 M | 44.63% | 1.23% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 951.96 K | $55.36 M | 73.84% | 1.20% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 840.07 K | $48.85 M | 28.11% | 1.06% |
| COMMODORE CAPITAL LP | 05/15/2026 | 825.00 K | $47.97 M | -54.17% | 1.04% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2026 | 786.84 K | $45.75 M | -1.61% | 0.99% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 769.88 K | $44.77 M | 10.61% | 0.97% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 763.02 K | $44.37 M | -3.14% | 0.96% |
| FIERA CAPITAL CORP | 05/12/2026 | 709.53 K | $41.26 M | 3.42% | 0.90% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 679.71 K | $39.23 M | 8.58% | 0.86% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 679.31 K | $39.50 M | -0.17% | 0.86% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 639.90 K | $37.21 M | 6.65% | 0.81% |
| ABRDN PLC | 04/29/2026 | 609.93 K | $35.47 M | -18.71% | 0.77% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 606.09 K | $35.24 M | 38.77% | 0.76% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 588.71 K | $34.23 M | 21.23% | 0.74% |
| LOOMIS SAYLES & CO L P | 05/14/2026 | 564.90 K | $32.85 M | -7.70% | 0.71% |
| 05/08/2026 | 543.06 K | $31.58 M | 100.00% | 0.69% | |
| NORTHERN TRUST CORP | 05/14/2026 | 527.78 K | $30.69 M | 20.30% | 0.67% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 497.04 K | $28.90 M | 222.36% | 0.63% |
| TUDOR INVESTMENT CORP ET AL | 05/15/2026 | 495.59 K | $28.82 M | 95.11% | 0.63% |
| OCTAGON CAPITAL ADVISORS LP | 05/15/2026 | 490.00 K | $28.49 M | 100.00% | 0.62% |
| NOVO HOLDINGS A/S | 05/15/2026 | 485.44 K | $28.23 M | 100.00% | 0.61% |
| CANDRIAM S.C.A. | 04/30/2026 | 476.49 K | $27.71 M | 14.16% | 0.60% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xenon Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 344 institutional investors and hedge funds held shares of Xenon Pharmaceuticals Inc. The most heavily invested institutionals were:
FMR LLC: 10.82 M
Avoro Capital Advisors LLC: 5.78 M
BlackRock, Inc.: 5.64 M
WELLINGTON MANAGEMENT GROUP LLP: 4.83 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 4.49 M
Polar Capital Holdings Plc: 4.41 M
126.46% of Xenon Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 106.13 M shares in the last 24 months. This purchase volume represents approximately $6.66 B in transactions.